Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.5.0.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Revenue:        
Products, services, other $ 500,949 $ 481,452 $ 1,429,487 $ 1,174,391
Grant revenue 34,385 98,882 127,289 259,181
Total revenue 535,334 580,334 1,556,776 1,433,572
Costs and expenses:        
Cost of products and services 262,894 209,804 727,698 575,780
Research and development 268,317 355,574 925,015 878,899
Selling and marketing 224,380 207,888 609,501 574,289
General and administrative 231,550 497,796 1,853,010 2,034,040
Total operating costs and expenses 987,141 1,271,062 4,115,224 4,063,008
Operating loss (451,807) (690,728) (2,558,448) (2,629,436)
Other (expense) income:        
Interest expense, net (1,116,328) (1,584,830) (2,961,708) (2,831,106)
Other expense (200) (1,112) (36,910)
Gain on extinguishment of embedded derivative liabilities 1,180,251 2,028,324
Change in fair value of derivative liabilities 623,128 437,379 (412,500) 38,968
Total other (expense) income (493,400) 32,800 (3,375,320) (800,724)
Net loss (945,207) (657,928) (5,933,768) (3,430,160)
Accrued dividends on convertible preferred stock 1,711 (21,768)
Net loss applicable to common shareholders $ (945,207) $ (656,217) $ (5,933,768) $ (3,451,928)
Net loss per share attributable to common stockholders - basic and diluted $ (0.03) $ (0.03) $ (0.23) $ (0.17)
Weighted average common stock shares outstanding used in the basic and diluted net loss per share calculation 29,425,362 20,737,827 26,139,740 19,771,323